David Kudrow

ARISE: A Phase 3 randomized trial of erenumab for episodic migraine

David W. Dodick, Messoud Ashina, Jan Lewis Brandes et al. · Cephalalgia · 2018 · 570 citations

Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial

David W. Dodick, Peter J. Goadsby, Stephen D. Silberstein et al. · The Lancet Neurology · 2014 · 369 citations

Gene-related Peptide, Cluster Headache, Frequent Episodic Migraine +6

Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial

Robert Croop, Richard B. Lipton, David Kudrow et al. · The Lancet · 2020 · 334 citations

Cluster Headache, Oral Rimegepant, Placebo-controlled Trial +7

Sumatriptan-Naproxen for Acute Treatment of Migraine

Jan Lewis Brandes, David Kudrow, Stuart R. Stark et al. · JAMA · 2007 · 269 citations

Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double‐Blind, Sham‐Controlled ACT1 Study

Stephen D. Silberstein, Laszlo Mechtler, David Kudrow et al. · Headache The Journal of Head and Face Pain · 2016 · 248 citations · Full text